TRAIL-Based High Throughput Screening Reveals a Link between TRAIL-Mediated Apoptosis and Glutathione Reductase, a Key Component of Oxidative Stress Response

作者: Dmitri Rozanov , Anton Cheltsov , Eduard Sergienko , Stefan Vasile , Vladislav Golubkov

DOI: 10.1371/JOURNAL.PONE.0129566

关键词: GlutathioneProgrammed cell deathCell biologyReactive oxygen speciesGlutathione reductaseBiologyMitochondrionOxidative stressCancer cellMolecular biologyApoptosis

摘要: A high throughput screen for compounds that induce TRAIL-mediated apoptosis identified ML100 as an active chemical probe, which potentiated TRAIL activity in prostate carcinoma PPC-1 and melanoma MDA-MB-435 cells. Follow-up silico modeling profiling cell-based assays allowed us to identify NSC130362, pharmacophore analog of induced 65-95% cytotoxicity cancer cells did not affect the viability human primary hepatocytes. In agreement with activation apoptotic pathway, both NSC130362 synergistically caspase-3/7 Subsequent affinity chromatography inhibition studies convincingly demonstrated glutathione reductase (GSR), a key component oxidative stress response, is target NSC130362. accordance role GSR gene silencing but Inhibition resulted induction stress, was evidenced by increase intracellular reactive oxygen species (ROS) peroxidation mitochondrial membrane after treatment The antioxidant reduced (GSH) fully protected from cell lysis TRAIL, thereby further confirming interplay between TRAIL. As consequence combined different inducers promoted death variety hepatocytes vivo, mouse tumor xenograft model.

参考文章(63)
Giuliano Ramadori, Silke Cameron, Effects of systemic chemotherapy on the liver. Annals of Hepatology. ,vol. 9, pp. 133- 143 ,(2010) , 10.1016/S1665-2681(19)31651-5
Hongqiao Zhang, Henry Jay Forman, Jinah Choi, γ‐Glutamyl Transpeptidase in Glutathione Biosynthesis Methods in Enzymology. ,vol. 401, pp. 468- 483 ,(2005) , 10.1016/S0076-6879(05)01028-1
Carman Giacomantonio, Jamie S. Mader, Helen Fawcett, Matthew Robichaud, David W. Hoskin, Contribution of reactive oxygen species and caspase-3 to apoptosis and attenuated ICAM-1 expression by paclitaxel-treated MDA-MB-435 breast carcinoma cells. International Journal of Oncology. ,vol. 27, pp. 1717- 1726 ,(2005) , 10.3892/IJO.27.6.1717
Laura DeForge, Jeanine Bussiere, Judith A. Fox, Klara Totpal, Sean K. Kelley, David Xie, Louise A. Harris, Preclinical Studies to Predict the Disposition of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Humans: Characterization of in Vivo Efficacy, Pharmacokinetics, and Safety Journal of Pharmacology and Experimental Therapeutics. ,vol. 299, pp. 31- 38 ,(2001)
B. Jovanovic, Ann D. Thor, Rajesh V. Kamath, D. J. Leary, J. Wang, R. Nayar, Sui Huang, F. Shi, Chen Wang, P. Kovarik, Alicja Slusarczyk, E. L. Wiley, Qiu-Liang Wu, Susan M. Edgerton, Perinucleolar Compartment Prevalence Has an Independent Prognostic Value for Breast Cancer Cancer Research. ,vol. 65, pp. 246- 253 ,(2005)
J. Lu, E.-H. Chew, A. Holmgren, Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 12288- 12293 ,(2007) , 10.1073/PNAS.0701549104
Hideo Yagita, Kazuyoshi Takeda, Yoshihiro Hayakawa, Mark J. Smyth, Ko Okumura, TRAIL and its receptors as targets for cancer therapy. Cancer Science. ,vol. 95, pp. 777- 783 ,(2004) , 10.1111/J.1349-7006.2004.TB02181.X
Lara Gibellini, Marcello Pinti, Milena Nasi, Sara De Biasi, Erika Roat, Linda Bertoncelli, Andrea Cossarizza, Interfering with ROS Metabolism in Cancer Cells: The Potential Role of Quercetin Cancers. ,vol. 2, pp. 1288- 1311 ,(2010) , 10.3390/CANCERS2021288
Albert G. Remacle, Vladislav S. Golubkov, Sergey A. Shiryaev, Russell Dahl, John L. Stebbins, Andrei V. Chernov, Anton V. Cheltsov, Maurizio Pellecchia, Alex Y. Strongin, Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth. Cancer Research. ,vol. 72, pp. 2339- 2349 ,(2012) , 10.1158/0008-5472.CAN-11-4149